Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry

scientific article

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/MYC.12212
P698PubMed publication ID24943384

P2093author name stringCarol A Kauffman
Billy Franks
Alison G Freifeld
David L Horn
Mindy G Schuster
Nkechi E Azie
P2860cites workFusarium infections in immunocompromised patientsQ24685627
Fusarium infection: report of 26 cases and review of 97 cases from the literatureQ27014001
Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other ConditionsQ29399166
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infectionsQ31130694
Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testingQ31149815
Human fusariosisQ33975373
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.Q34151084
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.Q35181927
Infections caused by Fusarium speciesQ35622021
The challenge of managing fusariosisQ35693680
Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assayQ35806844
Treating disseminated fusariosis: amphotericin B, voriconazole or both?Q36808076
Contact lens-related Fusarium infection: case series experience in New York City and review of fungal keratitisQ36997658
Fusarium infection in lung transplant patients: report of 6 cases and review of the literatureQ37114436
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/Q37164067
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.Q38025819
Fusarium infection in hematopoietic stem cell transplant recipientsQ44883924
P433issue11
P304page(s)652-658
P577publication date2014-06-18
P1433published inMycosesQ1956531
P1476titleTreatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry
P478volume57

Reverse relations

cites work (P2860)
Q92156299Blood culture and antimicrobial susceptibility pattern of bacteria and fungi isolated from febrile neutropenic patients treated with chemotherapy at Taleghani hospital, Tehran
Q40451792Burden of fungal infections in Qatar.
Q64075702Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient
Q54503425Disseminated fusariosis with endophthalmitis after skin trauma in acute lymphoblastic leukaemia.
Q57745968FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging
Q41733907Fatal disseminated infection with Fusarium petroliphilum.
Q38786385Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Q35923853Fusarium ramigenum, a novel human opportunist in a patient with common variable immunodeficiency and cellular immune defects: case report
Q26750950Fusarium: Molecular Diversity and Intrinsic Drug Resistance
Q28354154Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015
Q35916585Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience
Q58418132Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach
Q46789764Proximal subungual onychomycosis caused by Fusarium falciforme successfully cured with posaconazole.
Q49257990Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern
Q40357629Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
Q88748282Synthesis and Evaluation of a Series of Bis(pentylpyridinium) Compounds as Antifungal Agents
Q39189670The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Q26746016Therapeutic Drug Monitoring of Posaconazole: an Update
Q38965488Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings

Search more.